Weekly Docetaxel/Irinotecan for Non-resectable Gastric Cancers After Cisplatin Plus 5-FU/Leucovorin

PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

June 30, 2000

Primary Completion Date

December 31, 2010

Study Completion Date

June 30, 2011

Conditions
Gastric Cancer
Interventions
DRUG

Docetaxel-Irinotecan

Docetaxel-Irinotecan, weekly, days 1, 8, 15, repeated every 4 weeks

Trial Locations (1)

100

Department of Oncology, National Taiwan University Hospital, Taipei

All Listed Sponsors
collaborator

Far Eastern Memorial Hospital

OTHER

lead

National Taiwan University Hospital

OTHER

NCT00166881 - Weekly Docetaxel/Irinotecan for Non-resectable Gastric Cancers After Cisplatin Plus 5-FU/Leucovorin | Biotech Hunter | Biotech Hunter